.Only 5 months after protecting a $100 million IPO, Limitless Bio is actually actually laying off so...
.The first phases of oncology R&D may not be except appealing brand new techniques, and Halda Reh...
.Psychopharmacology has actually pulled three short articles regarding midstage professional trial d...
.Avidity Biosciences amazed real estate investors with phase 1/2 records in Duchenne muscular dystro...
.Actinogen Medical's cortisol blocker has actually missed out on the main endpoint of a phase 2 rese...
.Antibody-drug conjugates (ADCs) have actually gone to the facility of lots of a billion-dollar biob...
.Asset manager TPG, which has actually sustained biotechs including Sionna Therapies and also Santa ...
.Merck & Co.'s TIGIT system has actually suffered an additional obstacle. Months after shuttering...
.After a year described by pipeline cuts, the variation of its own CEO and discharges, Exscientia wi...
.Cullinan Therapeutics was made an impression on good enough with Port BioMed's bispecific immune sy...